J8520 – Capecitabine, oral, 150 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ8520
- Long description
- Capecitabine, oral, 150 mg
- Short description
- Capecitabine, oral, 150 mg
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 2000
- Last change
- October 1, 2024 – No change
- Termination date
- September 30, 2024
Frequently asked questions
What is HCPCS code J8520?
J8520 is a HCPCS Level II code for capecitabine, oral, 150 mg. It was discontinued on September 30, 2024.
Does Medicare cover J8520?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7799 – Noc drugs, other than inhalation drugs, administered through dme
- J7999 – Compounded drug, not otherwise classified
- J8498 – Antiemetic drug, rectal/suppository, not otherwise specified
- J8499 – Prescription drug, oral, non chemotherapeutic, nos
- J8501 – Aprepitant, oral, 5 mg
- J8502 – Injection, aprepitant (aponvie), 1 mg
- J8510 – Busulfan; oral, 2 mg
- J8515 – Cabergoline, oral, 0.25 mg
- J8521 – Capecitabine, oral, 500 mg
- J8522 – Capecitabine, oral, 50 mg
- J8530 – Cyclophosphamide; oral, 25 mg
- J8540 – Dexamethasone, oral, 0.25 mg
- J8541 – Dexamethasone (hemady), oral, 0.25 mg
- J8560 – Etoposide; oral, 50 mg
- J8562 – Fludarabine phosphate, oral, 10 mg
- J8565 – Gefitinib, oral, 250 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.